An analysis published in February of this year in the Journal of the American College of Radiology explains that low-dose CT lung cancer screening screens are effective tools for reducing disease mortality among high-risk individuals. However, it is known that the use of these programs is still low. So, they ask: what can be done to remedy this situation?

The Radiology Business website explained a little about the analysis and issues it addresses, such as the fact that LCS programs can track individuals who are not necessarily eligible to be screened.

To find out more, access the news here.